Latest Videos
Video
Drug Discovery and CROs: A Journey Beyond Spreadsheets and Email
In this episode, we speak with Chris Stumpf, Director, Drug Discovery Informatics Solutions at Revvity Signals.
Video
Accelerating Single-Cell Analysis and Screening with the Power of Picodroplets
In this Teach Me in 10 video, we'll explore the acceleration of single-cell analysis and screening within the drug discovery process.
Video
Explore How To Publish Detailed Research Without Constraints
Learn about Open Access Publishing and the new publishing platform Octopus in our latest episode of Teach Me in 10.
Video
How Automated Protein Analysis Leads to Reliable Results
In this Teach Me in 10, Heather James speaks with Dr. Kyle Luttgeharm, a Senior Product Manager with Agilent Technologies, about their new ProteoAnalyzer system.
Video
Thawing and Plating Cryoplateable Hepatocytes
To help ensure your ADME-Tox data is as accurate as possible, BioIVT developed a short instructional video with useful information and tips on thawing and plating hepatocytes. Take a look to make sure you maximize the performance of your cells!
Video
How To Accelerate Research and Drug Discovery in Motor Neuron Disease: A Deep Dive Into Precision Reprogrammed Human iPSC-Derived Motor Neurons
In the Teach Me in 10 video, Dr. Marcos Herrera-Vaquero, bit.bio discusses motor neurons and their critical role in Motor Neuron Diseases (MNDs) such as amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA).
Video
Reveal the Power of the 6-Base Genome for Transformative Insights Into Current and Future States of Disease
In this episode we speak with Tom Charlesworth and discuss how the 6-base genome can improve the understanding tumour biology from liquid biopsy.
Video
Organoids in Industry: Disease Modeling Platforms To Accelerate Drug Discovery
In this Teach me in 10 we're exploring disease modeling platforms that expedite drug discovery processes.
Video
Safety Considerations for the Development of Antibody Drug Conjugates
Both the antibody and small molecule of an ADC can contribute to drug interactions, so they should be considered from a safety perspective. However, regulatory guidance is not well established. Here’s what you need to know.
Video
Weekly Science News Roundup
Check out our top story highlights from the week!
Advertisement